Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Goat milk formula could offer cheap, safe option for infants

NCT ID NCT07225153

Knowledge-focused Sponsor: Aga Khan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a goat milk-based formula alternative (GMDFA) in 15 infants aged 8-10 weeks who cannot exclusively breastfeed. Researchers compare growth, gut health, and nutrition markers between infants fed GMDFA, undiluted goat milk, or breast milk. The goal is to see if GMDFA is a safe and affordable option for families in rural Pakistan.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Goat Milk-Derived Formula Alternative (GMDFA)
What this could lead to
If successful, this could provide an affordable, safe alternative to commercial infant formula for families with access to goat milk.
What could go wrong
This is a very small, early-stage study with only 15 infants, so results may not apply broadly. The formula is not yet proven to be nutritionally complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 10 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Infants aged = 08 -10 weeks with WAZ better than -1.8. (NIPS \& ICF, 2019) Age Sex WAZ Weight in Kilograms 2 Month Boys WAZ\>-1.8 4-5 kg 2 Month Girls WAZ\>-1.8 4-5 kg Table 3: WAZ scores * Living in Matiari District. * Who has access to goat milk in their households. * The Breastfeeding group: Women who exclusively breastfeeding and not giving and sort of formula or animal derived milk. * Intervention Group: Women who do not breastfeed at all or give goat milk to their infants (2-3 feeds per day). * No birth deformities Exclusion Criteria: * • Infant birth weight \< WAZ -1.8 i.e. weight-for-age based on established growth standards, such as the World Health Organization (WHO). * Birth deformities or disorders, such as genetic disorders, aerodigestive problems, or congenital anomalies. * Plan to migrate during the next six months. * We will exclude the women who exclusive breast feed and continue breast feeding for first 4 months. * If the child is enrolled or included in any other interventional trial. * Who does not have access to goat milk in their households. * Are medically disqualified: Any potential participant who is deemed medically unfit for enrollment, due to the presence of severe or unstable health conditions that could compromise safety or interfere with the study outcomes, will be excluded from participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Growth flatering are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding Infant Nutrition Disorders Malnutrition nutritional deficiency disease nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Growth flatering Gut microbiome Infant growth gut health intestinal inflammation biomarkers Infant nutrition disorder Infant nutrition infant growth feeding practices Lipidomics Malnutrition (calorie) Malnutrition prevention infant feeding growth outcomes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • MATIARI Research & Training Centre

    RECRUITING

    Matiāri, Sindh, 45330, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.